thumbnail image
broken image
broken image

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LeukoPrint
    • PanCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
      • PanCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry
broken image
broken image

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LeukoPrint
    • PanCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
      • PanCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry
broken image
  • SeekIn envisions that by leading a new norm for cancer early detection the clinical outcome of mid-/late-stage cancer patients can be reversed and the cancer mortality rate can be reduced by 15%.

    Explore SeekIn's products
  • About Us

    broken image

    SeekIn Inc. is a biotech company founded in 2017, focusing on blood-based pan-cancer early detection utilizing next-generation sequencing and artificial intelligence. Since its creation, SeekIn has been committed to providing cutting-edge and cost-effective solutions for cancer early detection, postoperative recurrence monitoring, and treatment response evaluation. SeekIn has also developed novel molecular tests for leukemia patients, and its cancer early detection technology has been successfully applied to canines. With its proprietary technical advances, SeekIn has launched a number of research and clinical studies in collaboration with top-tier hospitals in Europe and China. SeekIn envisions that, by leading a new norm for cancer early detection, the clinical outcomes of mid-/late-stage cancer patients can be reversed, and the cancer mortality rate can be reduced by 15%.

  • The management team of SeekIn consists of experts with insightful and complementary experiences in R&D, clinical lab management, business operations, corporate finance, and product commercialization.

    See the founder

    In October 2020,Dr. Mao Mao was invited to give a talk on TEDxTheBoud's annual meeting again (TEDxTheBund talk in 2018). As TED's vision is the power of ideas to change the world, his wish is to use early detection to control cancer, the emperor of all maladies.

     

    I hope that with all our efforts today, when we identify a positive case, the person will say to me, "Dr. Mao, no worries. I just have cancer".

    ——— Mao Mao

    Dr. Mao Mao's TEDxTheBund talk in 2020

    In 2024, Dr. Mao Mao was invited to deliver a speech on the AACR Annual Meeting, the world's largest cancer research conference.

     

    Early cancer detection can improve cure rates and five-year survival rates, yet many established cancer screening technologies are not suitable for use in low- and middle-income countries due to their cost, complexity, and reliance on extensive medical infrastructure. OncoSeekTM is designed to address these challenges.

    ——— Mao Mao

    Dr. Mao Mao 's AACR Annual Meeting talk in 2024

  • Our Solution

    multiplex, stepwise, cost-effective blood-based cancer screening

    broken image

     

    A NGS test to capture cancer genetic features in plasma

    broken image

     

    To calculate cancer risk score

    broken image

     

    Non-invasive blood based screening method,10ml blood

  •  

    Newsroom

    Accelerating early cancer detection in Latin America: Biotecgen enters...
    June 18, 2025 · Media Resources
    SeekInCare: New Multi-Omics Blood Test Shows Promise for Early Cancer...
    June 2, 2025 · Media Resources
    SeekIn to Present Cancer Early Detection Technologies at the 2025 ASCO...
    May 30, 2025 · Press Releases
    From Non-Invasive Early Detection to Treatment Response Monitoring: ...
    May 20, 2025 · Press Releases
    2025 European Debut: SeekIn Presents Cost-Effective Two-Step Multi-Cancer...
    May 15, 2025 · Press Releases
    Longevity Medical Institute™ Integrates OncoSeek® to Launch One of ...
    April 8, 2025 · Media Resources
    More Posts
  •  

    Partnerships

    broken image
    broken image
    broken image
    broken image
    broken image
    broken image
    broken image
    broken image
    broken image

Navigation

Technology   

SeekInCare

SeeInCure

SeekInClarity

OncoSeek

Research

Contact Us

10320 Camino Santa Fe, Suite G

San Diego, CA 92121

United States

info@seekincancer.com

© 2024 SeekIn Inc.

All Rights Reserved.

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More